ClinicalTrials.Veeva

Menu

Impact of Ultra-Early Intracranial Aneurysm Treatment in SAH (UEAT)

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Completed

Conditions

Subarachnoid Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT03894202
GWHMRF2018001
06170516 (Other Grant/Funding Number)

Details and patient eligibility

About

This is the first prospective study in Hong Kong that recruit patients with poor neurological status after intracranial aneurysm rupture in all seven public neurosurgical services in Hong Kong. This study assesses whether ultra-early aneurysm treatment improves outcomes in patients with poor neurological status after intracranial aneurysm rupture in Hong Kong. These data are essential to understand the impact of the disease and for future service development in Hong Kong.

Full description

Objectives:

  1. To evaluate outcomes in patients admitted with poor neurological status after intracranial aneurysm rupture in Hong Kong;
  2. To evaluate whether ultra-early aneurysm treatment improves outcomes in patients admitted with poor neurological status after intracranial aneurysm rupture.

Hypothesis to be tested: Ultra-early aneurysm treatment increases chance of favorable outcomes in in patients admitted with poor neurological status after intracranial aneurysm rupture.

Design and subjects: Prospective observational study to recruit consecutive poor grade aneurysmal subarachnoid hemorrhage patients in the seven public neurosurgical services in Hong Kong.

Study instruments: Modified Rankin Scale, Montreal Cognitive Assessment, Stroke-Specific Quality of Life, Short Form-36, Return to Work, and hospital resource utilization.

Groups: Ultra-early (within initial 24 hours) and non-ultra early aneurysm treatment.

Main outcome measures: Favorable outcome at six months. Data analysis and expected results: Comparisons are carried out with adjustments for age, sex, admission Glasgow Coma Scale, hypertension, and modality of aneurysm treatment with appropriate regression analyses.

Enrollment

293 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

The inclusion criteria for this study are:

  1. Adult patients (aged >18 years) with spontaneous subarachnoid hemorrhage
  2. Admission into Hospital Authority neurosurgical services
  3. The Glasgow Coma Scale on admission ≤12 (World Federation of Neurosurgical Societies Grade 4-5)

The exclusion criteria for this study are:

  1. Patients are likely to leave Hong Kong shortly after episode
  2. Patients (or next-of-kin as appropriate) refuse to participate into the study

Trial design

293 participants in 2 patient groups

Ultra-early aneurysm treatment
Description:
Ultra-early aneurysm treatment is defined as definitive cerebral aneurysm treatment such as coiling or clipping within the initial twenty-four hours.
Non-ultra-early aneurysm treatment
Description:
Non-ultra-early aneurysm treatment is defined as definitive cerebral aneurysm treatment such as coiling or clipping after the initial twenty-four hours.

Trial contacts and locations

1

Loading...

Central trial contact

Carol MF Chan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems